Detalhe da pesquisa
1.
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
N Engl J Med
; 385(20): 1856-1867, 2021 11 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34534429
2.
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 24(4): 392-402, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36878237
3.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Future Oncol
; 19(11): 739-752, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36919706
4.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet
; 398(10294): 27-40, 2021 07 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34102137
5.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(2): 198-211, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33476593
6.
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
N Engl J Med
; 378(22): 2093-2104, 2018 May 31.
Artigo
Inglês
| MEDLINE | ID: mdl-29658845
7.
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
N Engl J Med
; 378(14): 1277-1290, 2018 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29562145
8.
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
Lancet Oncol
; 20(10): 1370-1385, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31427204
9.
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial.
Lancet Oncol
; 14(6): 490-9, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23594786
10.
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses From the KEYNOTE-826 Randomized Clinical Trial.
JAMA Oncol
; 10(2): 185-192, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38095881
11.
Addressing the unmet needs of patients with BRAF-mutated melanoma in Latin America: Expert perspective.
Front Oncol
; 13: 1032300, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36998456
12.
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial.
J Clin Oncol
; 41(11): 1957-1964, 2023 04 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37018920
13.
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.
J Clin Oncol
; 41(36): 5505-5511, 2023 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37910822
14.
Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma.
NEJM Evid
; 2(4): EVIDoa2200239, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38320023
15.
Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety.
Ecancermedicalscience
; 15: 1168, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33680082
16.
Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries.
JCO Glob Oncol
; 7: 545-549, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33856892
17.
First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in Advanced NSCLC With 1% or Greater Tumor PD-L1 Expression: Patient-Reported Outcomes From CheckMate 227 Part 1.
J Thorac Oncol
; 16(4): 665-676, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33485960
18.
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial.
J Immunother Cancer
; 8(2)2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32661118
19.
Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin America.
Adv Ther
; 36(12): 3446-3457, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31630333
20.
Unraveling the complex link between vitamin D levels and cancer: A crucial understanding for designing future supplementation approaches
Braz. J. Pharm. Sci. (Online)
; 59: e23319, 2023. tab, graf
Artigo
Inglês
|
LILACS-Express
| ID: biblio-1520319